grant
Harvard University — Antiviral Research (2022)
Metadata
| Source Table | grants |
| Source ID | c1oO5Ic7NK |
| Description | to harvard-university, $2,500,000, 2022-01 |
| Source URL | coefficientgiving.org/grants/ |
| Parent | ULjDXpSLCI |
| Children | — |
| Created | Mar 12, 2026, 5:54 AM |
| Updated | Mar 23, 2026, 3:17 PM |
| Synced | Mar 19, 2026, 8:57 PM |
Record Data
id | c1oO5Ic7NK |
organizationId | Coefficient Giving(organization) |
granteeId | Harvard University(organization) |
orgEntityId | Coefficient Giving(organization) |
orgDisplayName | — |
granteeEntityId | Harvard University(organization) |
granteeDisplayName | harvard-university |
name | Harvard University — Antiviral Research (2022) |
amount | 2500000 |
currency | USD |
period | — |
date | 2022-01 |
status | — |
source | coefficientgiving.org/funds/ |
notes | [Science Supporting Biosecurity and Pandemic Preparedness] Open Philanthropy recommended a grant of $2,500,000 over three years to Harvard University to support research led by Dr. Donald Ingber on a novel class of antiviral drugs with special emphasis on viruses with pandemic potential. This falls… |
programId | IVKWfIkgOz |
dataSourceId | — |
Source Check Verdicts
confirmed95% confidence
Last checked: 4/9/2026
[deterministic-row-match] Deterministic match: grantee, amount, date matched in source snapshot (2714 rows)
Debug info
Thing ID: c1oO5Ic7NK
Source Table: grants
Source ID: c1oO5Ic7NK